We’re dedicated in developing and advancing infrared (IR) thermal imaging for diagnostic use. From the very beginning, the company has invested in research and development of IR thermal imaging in various medical applications.
The IR thermal imaging technology developed by the company has been applied in different University research projects and is in clinical use in several University Hospitals and private clinics in Finland. The company has recently expanded its presence also in markets outside Finland, and has offices in the UK, Germany and the USA.
TherMidas has two business areas, one focusing on medical conditions, and the other, TherMidas VET, on veterinary applications.
The tremendous technological development of the last few decades has allowed IR thermal imaging to emerge as a novel, significant diagnostic imaging method alongside conventional imaging methods.
Thermidas has been assessed and certified as meeting the requirements of ISO 13485:2016 for the design and manufacturing of infrared imaging systems for medical purposes.
ISO 13485:2016 specifies requirements for a quality management system where an organization needs to demonstrate its ability to provide medical devices and related services that consistently meet customer and applicable regulatory requirements
As of January 6th 2021, Thermidas IR System ThIR-A615 has received FDA clearance.